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Abstract
Background: Numerous proteins can be converted to amyloid-like fibrils to increase cytotoxicity
and induce apoptosis, but the methods generally require a high concentration of protein, vigorous
shaking, or fibril seed. As well, the detailed mechanism of the cytotoxic effects is not well
characterized. In this study, we have developed a novel process to convert native proteins into the
fibrillar form. We used globular bovine serum albumin (BSA) as a model protein to verify the
properties of the fibrillar protein, investigated its cellular effects and studied the signaling cascade
induced by the fibrillar protein.
Results: We induced BSA, a non-cytotoxic globular protein, to become fibril by a novel process
involving Superdex-200 column chromatography in the presence of anionic or zwittergenic
detergent(s). The column pore size was more important than column matrix composite in fibril
formation. The fibrillar BSA induced apoptosis in BHK-21 cell as well as breast cancer cell line
T47D. Pre-treating cells with anti-integrin antibodies blocked the apoptotic effect. Fibrillar BSA, but
not globular BSA, bound to integrin, dephosphorylated focal adhesion kinase (FAK), Akt and
glycogen synthase kinase-3β (GSK-3β).
Conclusion: We report on a novel process for converting globular proteins into fibrillar form to
cause apoptosis by modulating the integrin/FAK/Akt/GSK-3β/caspase-3 signaling pathway. Our
findings may be useful for understanding the pathogenesis of amyloid-like fibrils and applicable for
the development of better therapeutic agents that target the underlying mechanism(s) of the
etiologic agents.
Background
After glycation [1], sonication [2], or incubation at high
temperature [3-7], numerous proteins can be converted to
amyloid-like fibrils with common properties such as more
notable β-structure, fibrillar morphology, protofilament
substructure, cross-β diffraction pattern, and binding to
Congo red or amyloid-specific dye thioflavin T (ThT) [8-
12]. The formation of amyloid fibrils can be promoted by
the presence of ethanol [7,13], sodium dodecyl sulfate
(SDS) [14-16], or other anionic detergents [17]. However,
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these methods generally require a high concentration of
protein, vigorous shaking, or the addition of fibril seed
and are not easy to isolate fibrillar protein from others
such as oligomers, protofibrils or non-fibrillar proteins
that may also exist in the solution [1,2,7,15,16,18,19].
Amyloid fibrils are cytocytotoxic [20-23], however, it is
still debatable as to whether oligomers, mature fibrils,
protofibrils or target cellular types are the most critical fac-
tors in dictating cellular damage [24-27]. Study of disease-
associated proteins such as the amyloid-β peptide (Aβ), α-
synuclein, and transthyretin shows that common features
of specific types of aggregates rather than specific amino
acid sequences are positively related to cytotoxicity [28].
Amyloid oligomers from several different proteins have
been shown to share the ability to permeabilize cellular
membranes and lipid bilayers, which is thus proposed as
the primary toxic mechanism of amyloid pathogenesis
[26]. Lysozyme amyloid oligomers and fibrils, however,
exert cytotoxicity by acting within different time-scales
and via apoptosis-like and necrosis-like cell death, respec-
tively [23]. Study with human islet amyloid polypeptide
(hiAPP), the major constituent of islet amyloid, on the
other hand, shows that growth of hiAPP fibrils at the cel-
lular membrane, rather than pre-formed oligomers or
fibrils are responsible for the observed membrane damage
[27]. Recently, it has been demonstrated with specific
integrin-blocking antibodies that amyloid-β peptide (Aβ)
deposition and neurotoxicity in human cortical primary
neurons are mediated through α2β1 and αVβ1 integrin
receptors [29]. Whether binding of Aβ to integrin results
in change of down stream signaling molecules such as
Akt, Bad, forkhead transcription factors, glycogen syn-
thase kinase-3 (GSK-3β), caspase-9 and eventually lead to
apoptosis [30-35], however, has not been clarified.
Here we used a detergent-assisted refolding method [36]
developed previously for the refolding of recombinant
capsid protein VP1 of foot-and-mouth disease virus
(FMDV) to promote the formation of fibrillar proteins in
general. We chose a model protein, BSA, for evaluating
fibrillation of protein using the new method. Further-
more, the fibrillar BSA processed by this new method was
used to investigate the cellular effect and signaling cascade
of amyloid-like fibrils. Our findings suggest that amyloid-
like fibrillar BSA induced cellular cytotoxicity and apopto-
sis via modulating the integrin/focal adhesion kinase
(FAK)/Akt/GSK-3β/caspase-3 pathway.
Results
Conversion of globular protein into fibril by column 
chromatography
Under certain extreme conditions such as high tempera-
ture, glycation, or sonication, proteins can be refolded
and converted into fibrils [1-7]. In this study, BSA was
refolded by being dissolved in 1% SDS solution, passed
through the gel filtration column Superdex-200 and
eluted with buffer solution containing 25 mM Tris-HCl,
pH 8.0, 1 mM EDTA, 0.1 M NaCl, and 0.05% SDS (Fig. 1).
The refolded BSA protein obtained from the Superdex-
200 column (BSA-S200), like amyloid fibrils, exhibited
enhanced fluorescence level of amyloid-specific dye ThT
in a dose-dependent manner (Fig. 2A), as compared with
BSA not processed by the Superdex-200 column. These
results were substantiated by transmission electron micro-
scopy (TEM) analysis showing BSA with a globular struc-
ture (Fig. 2B) and BSA-S200 with a fibril structure (Fig.
2C).
To investigate the effect of gel-filtration column pore size
on the formation of fibrils, BSA was eluted with same
buffer through a gel filtration column with a smaller pore
size (Superdex-75) than that of the Superdex-200 column.
TEM analysis revealed that BSA eluted from Superdex-75
(BSA-S75), like BSA, showed a globular structure (Fig. 2D)
and no enhanced ThT fluorescence (Fig. 2A). The effect of
column matrix on fibrillar protein formation was further
examined with a HW55S gel filtration column with pore
size similar to that of Superdex-200 but a different matrix
composite. BSA eluted from HW55S chromatography
(BSA-HW55S), like BSA-S200, displayed a fibrillar struc-
ture (Fig. 2F). These data suggest that a molecular sizing
column such as Superdex-200 (S200) or HW55S with a
pore size more than 70 kDa promotes the formation of
amyloid-like fibrillar proteins in the presence of a low
concentration of SDS detergent.
We also investigated whether other detergents have the
same effect as SDS. BSA solution in the presence of 1%
Zwittergent 3–14, which retains its zwitterionic character
over a wide range of pH, was eluted from a Superdex-200
column with a buffer solution containing 25 mM Tris-
HCl, pH 8.0, 1 mM EDTA, 0.1 M NaCl, and 0.05% Zwit-
tergent 3–14. TEM revealed the BSA protein obtained
from a Superdex-200 column with Zwittergent 3–14
(BSA-Zwit), like BSA-S200, with a fibrillar structure (Fig.
2G). These data suggest that not only anionic detergent(s)
but also zwitterionic detergent(s) are effective in facilitat-
ing fibrillar protein formation.
Fibrillar BSA induces apoptosis in BHK-21 cells
Since amyloid-like fibrils are cytotoxic to neuronal cells
[20-23], we examined whether fibrillar BSAs induced by
our method are cytotoxic to cells, we treated BHK-21 cells
with various concentrations of BSA-S200, BSA-Zwit, or
BSA-HW55S in serum-free medium for 8 h. BSA-S200,
BSA-Zwit, and BSA-HW55S were all cytotoxic to cells in a
dose-dependent manner (Fig. 3A). BSA-Zwit exhibited the
strongest cytotoxicity among all tested. At 0.5 μM concen-
tration, it induced almost 100% cytotoxicity, whereasBMC Biotechnology 2009, 9:2 http://www.biomedcentral.com/1472-6750/9/2
Page 3 of 12
(page number not for citation purposes)
BSA-S200 induced 35% and BSA-HW55S 10% cytotoxic-
ity. The IC50 for BSA-Zwit, BSA-S200 and BSA-HW55S was
0.2, 0.75 and more than 10 μM, respectively. As controls,
two globular proteins, BSA and BSA-S75 induced little, if
any, cytotoxicity to cells (Fig. 3A). Interestingly, the cyto-
toxicity induced by all fibril BSAs (F-BSAs) in BHK-21 cells
was stronger than amyloid Aβ25–35 which induced a mere
10% cytotoxicity at concentrations as high as 40 μM after
8 h incubation (Fig. 3B). Significant number of cell death
induced by Aβ25–35 could be observed after 24 h incuba-
tion (Fig. 3C). Pre-treating BHK-21 cells with increasing
concentrations of globular BSA (G-BSA) did not reverse
the cytotoxicity induced by BSA-S200 (Fig. 3D). To exam-
ine whether F-BSA-induced cytotoxicity was related to cel-
lular apoptosis, DAPI staining and measurement of
caspase-3 activity were performed. Our results revealed
Formation of fibrillar BSA on Superdex-200 column chromatography Figure 1
Formation of fibrillar BSA on Superdex-200 column chromatography. (A) BSA (2 mg/ml dissolved in PBS containing 
1% SDS) was applied to a Superdex-200 column and eluted at the rate of 1 ml/min with a buffer solution containing 0.05% SDS. 
(B) Fractions from 23 to 33 were analyzed by SDS-PAGE and stained with Coomassie Blue. Lane A contains G-BSA as control. 
Before loading to the gel, the fibrillar BSA was solubilized in a sample buffer solution containing 1% SDS and β-mercaptoethanol 
and boiled for 10 min, which caused the fibrillar BSA to disassemble and migrate to the same position as G-BSA on SDS-PAGE.BMC Biotechnology 2009, 9:2 http://www.biomedcentral.com/1472-6750/9/2
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Analysis of fibrillar BSA by using ThT and transmission electron microscopy Figure 2
Analysis of fibrillar BSA by using ThT and transmission electron microscopy. (A) Comparison of fluorescence levels 
of increasing concentrations of G-BSA, BSA-S200, BSA-S75 and Aβ25–35 after incubating with 20 μM amyloid-specific dye ThT 
for 1 h. Amyloid Aβ25–35 that had been dissolved in sterile double-distilled water and aged at 37°C for 3 days was used as a pos-
itive control. The fluorescence level of G-BSA was similar to that of BSA-S75. Data are means ± S.D. (n = 3). TEM images show 
structure of G-BSA (B), BSA-S200 (C), BSA-S75 (D), Aβ25–35 (E), BSA-HW55S (F) and BSA-Zwit (G).BMC Biotechnology 2009, 9:2 http://www.biomedcentral.com/1472-6750/9/2
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Cytotoxic effect of Fibrillar BSAs Figure 3
Cytotoxic effect of Fibrillar BSAs. Cell viability was determined by the MTT assay. (A) BHK-21 cells were treated for 8 h 
with various concentrations of G-BSA, BSA-S75, BSA-S200, BSA-Zwit, or BSA-HW55S as indicated in serum-free medium. (B) 
BHK-21 cells were treated with increasing concentrations of Aβ25–35 in serum-free medium for 8 h. (C) BHK-21 cells were 
treated with increasing concentrations of Aβ25–35 or F-BSA (BSA-S200) in serum-free medium for 24 h. (D) BHK-21 cells were 
treated with or without increasing concentrations of G-BSA (BSA) for 1 h, then incubated with 0.5 μM F-BSA (BSA-S200) in 
serum-free medium for 8 h. Data are means ± S.D. (n = 3) of percentage of cell survival as determined by the MTT assays.BMC Biotechnology 2009, 9:2 http://www.biomedcentral.com/1472-6750/9/2
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that F-BSA induced nuclei condensation (Fig. 4A) and
increased caspase-3 activity (Fig. 4C) as compared with G-
BSA and Aβ25–35 (Fig. 4B). Taken together, these results
suggest that treatment with F-BSA induces cytotoxicity and
apoptosis of cells and this effect of F-BSA is not reversed
by treatment with G-BSA.
Fibrillar BSA induces apoptosis via integrin/FAK/Akt/GSK-
3β pathway
Being cytotoxic to BHK-21 cells, F-BSA was also cytotoxic
to cancer cells such as T47D cells (a breast cancer line)
(Fig. 5A). To examine whether the apoptotic effects of F-
BSA is via integrins known to modulate various processes
such as cell proliferation, morphology, migration, and
apoptosis [37-41], T47D cells were pre-treated with anti-
Evaluation of the apoptotic effect of fibrillar BSA Figure 4
Evaluation of the apoptotic effect of fibrillar BSA. (A) BHK-21 cells were incubated with 1 μM G-BSA (BSA) or F-BSA 
(BSA-S200) for 3 h. The cells were observed under a fluorescence microscope, and their nuclei were stained with DAPI (mag-
nification in all panels, ×400). (B) BHK-21 cells were incubated with 40 μM Aβ25–35 for 3 h. The cells were observed under a flu-
orescence microscope, and their nuclei were stained with DAPI (magnification in all panels, ×400). (C). BHK-21 cells were 
cultured with 0.8 μM G-BSA (BSA) or F-BSA (BSA-S200) for 15 h in serum-free medium, then underwent caspase-3 activity 
analysis measured by fluorogenic substrate as described under "Methods". Data are the mean ± SD of three experiments.BMC Biotechnology 2009, 9:2 http://www.biomedcentral.com/1472-6750/9/2
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integrin α5β1 antibody for 30 min, then incubated with
F-BSA (e.g., BSA-S200) for 8 h in serum-free medium. Cell
viability results revealed that pre-treating T47D cells with
anti-integrin α5β1 antibody but not goat IgG diminished
the cytotoxic effect of F-BSA (Fig. 5A). The interaction
between F-BSA and integrin was further verified by immu-
noprecipitation. Incubation of control beads or integrin
α5β1 protein-linked beads with G-BSA or F-BSA revealed
that F-BSA but not G-BSA bound to integrin α5β1 (Fig.
5B).
We then investigated whether the molecules involved in
the integrin signaling-pathway cascade, such as FAK, Akt
and GSK-3β, are affected by F-BSA. F-BSA dephosphor-
ylated FAK at Tyr 397 but not Tyr 576/577 in a time-
dependent manner (Fig. 6A). Western blot analysis
revealed that F-BSA dephosphorylated both Akt and GSK-
3β (Fig. 6B). The effect of F-BSA on Akt and GSK-3β phos-
phorylation could be reversed by pre-treating cells with
anti-integrin α5β1 antibody (Fig. 6B). In comparison, G-
BSA, as well as anti-integrin α5β1 antibody, had no effect
on the phosphorylation of Akt (Figs. 6C and 6D). Thus, F-
BSA induces apoptosis via an integrin/FAK/Akt/GSK-3β/
caspase-3 pathway.
Discussion
Although proteins usually fold to their native and func-
tional states, under certain conditions, some proteins may
fail to fold correctly and form fibrillar products with
abnormal biological effects [1-7]. One notable example of
incorrectly folded proteins is amyloid aggregate, which is
associated with Alzheimer's disease and transmissible
spongiform encephalopathy [20-23]. In the present study,
we used a simple column chromatography process to
induce native proteins, in this case, globular BSA, to
undergo fibrillization in the presence of detergent (SDS or
Zwittergent 3–14) (Figs. 2 and 3). Our findings are thus
consistent with a previous proposal that numerous pro-
teins with diverse structures, including both disease and
non-disease associated proteins, are capable of forming
fibril amyloid [42].
Aging proteins at 37°C may convert them into amyloid
fibrils, but, in most cases, aging requires days to weeks
[20-23]. Fibril formation can also be accelerated by SDS
[15,16] but still requires vigorous stirring overnight at
37°C with the addition of fibril seeds [15] or 2 days of
incubation at room temperature [16]. In addition, unless
aggregates form and precipitate out, these methods can-
not be used to isolate fibrillar from non-fibrillar proteins.
Our column chromatography process converts globular
protein into a fibrillar form in an efficient manner and
effectively separates the fibril from other forms of the pro-
tein. It is thus a novel approach for producing fibrillar
proteins.
We show that Superdex-200 and HW55S columns are
more efficient than Superdex-75 columns in converting
proteins into fibrillar forms. Even though Superdex-200
and HW55S have different matrix composite (cross-linked
agarose and dextran vs. hydroxylated methacrylic poly-
mer), they have similar pore size (10–600 vs. 1–700 kDa),
which is larger than that of Superdex-75 (3–70 kDa).
Although BSA-S200 was more potent than BSA-HW55S
(Fig. 3A), these findings seem to suggest, nonetheless, that
an appropriate bead pore size plays a crucial role in the
column-induced fibril formation, because fibrillization
was less with Superdex-75. A likely explanation is that the
proteins are reshaped to fibrillar form after entering the
pores and passing through the long channel inside the
column beads. Alternatively, the reshaping may be a con-
sequence of the greater overall stability resulting from fac-
tors such as an increase in van der Waals interactions in
the column bead. The explanation remains to be verified
by further studies.
Interaction between fibrillar BSA and integrin α5β1 Figure 5
Interaction between fibrillar BSA and integrin α5β1. 
(A) T47D cell lines were pre-treated with or without 0.67 
μM goat IgG or 0.67 μM goat anti-integrin α5β1 antibody for 
30 min as indicated, then incubated with 2 μM F-BSA (BSA-
S200) in serum-free medium for 8 h. Cell viability was deter-
mined by the MTT assay. Data are means ± S.D. (n = 3). (B) 
Integrin α5β1 protein was linked to protein A/G beads by 
use of anti-integrin α5β1 antibody, then incubated with F-
BSA (BSA-S200) or G-BSA (BSA) overnight. The immuno-
complexes were separated by SDS-PAGE and immunoblot-
ted with anti-integrin α5 and anti-BSA antibodies.BMC Biotechnology 2009, 9:2 http://www.biomedcentral.com/1472-6750/9/2
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Pertinhez et al. found that low concentrations of the ani-
onic detergent SDS promoted fibril formation [16] and
proposed that SDS might stimulate aggregation, perhaps
by associating with the peptide molecules; once such
aggregates are formed, intermolecular β-sheet interactions
are likely to develop readily. Several anionic detergents
have subsequently been found to be effective for fibrilliza-
tion [17]. We found that the effect of Zwittergent 3–14 on
the formation of cytotoxic BSA was similar to or even bet-
ter than that of SDS (Fig. 3). TEM showed that there was
few, if any, BSA oligomer or protofibril in the eluate of the
column chromatography, both BSA-S200 and BSA-Zwit
existed in the fibrillar form (Fig. 2C and 2G). The length
of BSA-Zwit was in average two fold longer than BSA-S200
(5,000 nm vs. 2,000 nm). As similar concentration of
fibrillar BSA-Zwit and BSA-S200 was used in the cytotoxic
assay, the difference in potency is likely due to factor(s)
other than concentration of amyloid fibrils. We are thus
the first to report that zwitterionic detergents are also
effective for promoting fibril formation. In addition, Zwit-
tergent 3–14, unlike SDS, contains both anionic and cati-
onic properties, so fibril formation may be stimulated by
not only anionic but also cationic properties of the deter-
gents. Further elucidating whether the detergents in this
process enhance fibril formation by increasing unfolding
or providing stability of the incorrectly refolded proteins,
or both, will be interesting.
Although G-BSA is not a ligand for integrin (Fig. 5B), F-
BSA caused cellular apoptosis by binding to integrin α5β1
(Figs. 4 and 5). Recently, Wright et al. [29] reported that
amyloid-β peptide (Aβ) bound to α2β1 and αVβ1 integrin
to activate Pyk2, as well as phosphorylated paxillin and
induced neurotoxicity. The authors did not, however,
detect any effect in the phosphorylation of FAK [29]. Here,
we report that F-BSA mediated cell apoptosis by binding
to integrin α5β1, which leads to the dephosphorylation of
FAK (Tyr 397), Akt and GSK-3β. The F-BSA produced in
this study therefore seemed to deactivate an integrin sign-
aling pathway via a mechanism different from that
induced by Aβ. Wright et al. used human cortical neurons,
whereas we used BHK-21 and T47D, so whether this dif-
ference in mechanism of action is due to the difference in
target cells or integrin receptors remains to be clarified.
Aβ and amyloid polypeptides usually undergo multistage
assemblies such as oligomers, protofibrils to become
fibrils [24-27,43,44]. Even though it is still debatable
which state of the polypeptide is more toxic to the cells,
the existing data seem to suggest that different assembled
macromolecular forms may exert cytotoxicity via different
mechanism of actions including membrane perturbation,
apoptosis, necrosis etc. [26,27,45-47]. Although fibril
proteins have been shown to cause caspase-related apop-
tosis [43,46,48], the details have not been explored. In
this study, we found that fibrillar BSA causes apoptosis by
modulating the integrin/FAK/Akt/GSK-3β/caspase-3 sign-
aling pathway.
Because BSA does not contain RGD, a unique binding
motif for integrin, it will be interesting to analyze whether
the mechanism of binding of fibrillar BSA to integrin is
the same as molecules with RGD in their sequence such as
vitronectin. Of note, even though some of the RGD-con-
taining peptides are cytotoxic, others, such as fibronectin,
are not [49]. In comparison, almost all fibrillar proteins
have been documented to cause cytotoxicity [20-23].
Thus, elucidating whether the mechanism of action of all
fibrillar proteins in causing cytotoxicity is due to the
involvement of a shared structural motif will be of inter-
est.
Detergents and column chromatography have routinely
been used to obtain membrane proteins close to their
native status [50]. However, whether the isolated mem-
brane proteins are cytotoxic and/or apoptotic has not
been reported. Our process could be used to isolate a few
membrane proteins to elucidate whether they are fibrillar
and apoptotic. If the membrane proteins isolated in this
manner do cause apoptosis, then the structure analysis of
membrane proteins isolated with the assistance of deter-
gents particularly those with SDS and zwittergents might
require re-examination.
Conclusion
We report on a novel process to convert globular proteins
such as BSA into fibrillar form. Unlike globular BSA,
which is non-cytotoxic, fibrillar BSA caused cell death by
modulating the integrin/FAK/Akt/GSK-3β/caspase-3 sign-
aling pathway. These findings may be useful for improv-
ing our understanding of the pathogenesis of amyloid-like
fibrils and applicable for the development of better thera-




The antibodies against phospho-Try576/577 FAK, phospho-
Ser473  Akt, and phospho-Ser9  GSK-3β were purchased
from Cell Signaling Technology (Beverly, MA, USA). The
antibody against phospho-Tyr397 FAK was obtained from
Biosource (Camirillo, CA, USA). Zwittergent 3–14 was
purchased from Calbiochem (San Diego, CA, USA).
Integrin α5β1 protein, anti-β-actin antibody, anti-integrin
α5 antibody, anti-integrin α5β1 antibody (function-
blocking antibody), goat IgG, horseradish peroxidase-
coupled anti-mouse IgG secondary antibodies, horserad-
ish peroxidase-coupled anti-rabbit IgG secondary anti-
bodies, and MTT assay kit were purchased from Chemicon
(Temecula, CA, USA). Anti-BSA antibody was obtainedBMC Biotechnology 2009, 9:2 http://www.biomedcentral.com/1472-6750/9/2
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Fibrillar BSA induced cytotoxicity via the integrin/FAK/Akt pathway Figure 6
Fibrillar BSA induced cytotoxicity via the integrin/FAK/Akt pathway. (A) BHK-21 cells were treated with 3 μM F-
BSA (BSA-S200) in serum-free medium for the indicated time, and cell lysates were analyzed by western blotting with anti-
phospho-FAK(Tyr576/577), anti-phospho-FAK(Tyr397), and anti-phospho-Akt (p-Akt) antibodies. (B) BHK-21 cells were pre-
treated for 30 min with or without 1 μM goat IgG or 1 μM goat anti-integrin α5β1 antibody as indicated, then treated with 3 
μM F-BSA (BSA-S200) in serum-free medium for 15 min. Cell lysates were analyzed by western blotting with anti-phospho-Akt 
(p-Akt) and anti-phospho-GSK-3β (p-GSK-3β) antibodies. (C) BHK-21 cells were treated with increasing concentrations of G-
BSA (BSA) in serum-free medium as indicated, and cell lysates were analyzed by western blotting with anti-phospho-Akt (p-
Akt) antibody. (D) BHK-21 cells were treated with or without 1 μM anti-integrin α5β1 antibody in serum-free medium for 30 
min, and cell lysates were analyzed by western blotting with anti-phospho-Akt (p-Akt) antibody.BMC Biotechnology 2009, 9:2 http://www.biomedcentral.com/1472-6750/9/2
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from Molecular Probes (Eugene, OR, USA). BSA was pur-
chased from Bio Basic Inc. (Markham, Ontario, Canada).
Aβ25–35, purchased from Sigma (St. Louis, MO, USA), was
dissolved in sterile double-distilled water and aged at
37°C for 3 days before use. Thioflavin T (ThT), sodium
dodecyl sulfate (SDS), 4', 6' – Diamidino-2-phenylindole
dilactate (DAPI), and other chemicals not otherwise spec-
ified were obtained from Sigma. Superdex-200 and Super-
dex-75 beads were obtained from Amersham Biosciences
(Uppsala, Sweden), HW55S gel filtration bead was
obtained from TOSOH Corporation (Shiba, Tokyo,
Japan).
Preparation of fibrillar BSAs (F-BSAs)
Twenty milligrams of BSA was dissolved in 10 ml of PBS
with 1% SDS (w/v). The BSA solution was sonicated for 5
min and subsequently applied to a Superdex-200 or a
HW55S column (2.6 × 100 cm), which was previously
equilibrated with the eluting solution (25 mM Tris-HCl,
pH 8.0, 1 mM EDTA, 0.1 M NaCl, and 0.05% SDS). The
column was eluted at the rate of 1 ml/min and fractions
28 – 32 that contained BSA were pooled. The pooled frac-
tions were then dialyzed against PBS to remove SDS. The
yield of the fibrillar BSA was about 67%. TEM showed that
the eluate of Sephadex-200 contained fibrillar BSA which
was not increased or decreased by the dialysis process
(data not shown).
Transmission electron microscopy (TEM)
For TEM analysis of fibrillar proteins, 1 mg/ml of protein
was applied to a 200-mesh carbon-coated copper grid.
Excess samples were removed, and the grid was air dried.
The protein-bearing grid was negatively stained with 1%
(W/V) phosphotungstic acid for 1 min. Transmission elec-
tron micrographs were observed at 20,000–150,000×
magnification at 75 kV on a Hitachi H-7000 electron
microscope.
Thioflavin T (ThT) fluorescence
Binding to ThT is one of the characteristics of amyloid-like
proteins [10]. For fluorescence measurements, increasing
concentrations of proteins (10 μM, 20 μM, and 40 μM)
were incubated with 20 μM ThT. After 1 h of incubation at
room temperature, fluorescence was measured in tripli-
cate on a Wallac VICTOR2 1420 Multilabel Counter (Per-
kin Elmer Life Science, Waltham, USA). Excitation and
emission wavelengths were 430 nm and 486 nm, respec-
tively. ThT background signal from buffer was subtracted
from corresponding measurements.
Cell lines and treatments
BHK-21 cells (baby hamster kidney; ATCC CRL-1632)
and T47D cells (human breast duct carcinoma; ATCC
HTB-133) were maintained at 37°C in Dulbecco's modi-
fied Eagle's medium (DMEM) supplemented with 10%
fetal bovine serum (FBS), 2 mM L-glutamine, 100 units/
ml penicillin, and 100 μg/ml streptomycin. In brief, cells
were seeded 24 h prior to treatment. The cells were
washed twice with PBS and incubated with proteins in
serum-free DMEM for the indicated time. Cells were then
lysed with 0.2 ml lysis buffer (Pierce, Rockford, USA) at
the indicated time points, and 30 μg of cell lysates were
analyzed for FAK, Akt, and GSK-3β phosphorylation by
western blot analysis.
Assay for cell survival and apoptosis
Cell survival was determined by MTT colorimetric assay.
Exponentially growing cells (1 × 104 cells/well for BHK-21
cells; 1.25 × 104 cells/well for T47D cells) were seeded in
96-well plates in DMEM with 10% FBS and incubated for
24 h. Treatment of cells with a series of concentrations of
proteins was carried out in serum-free DMEM for 8 h at
37°C. After treatment, MTT solution was added to each
well (0.5 mg/ml), followed by 4 h incubation. The viable
cell number is directly proportional to the production of
formazan, which, following solubilization with isopropa-
nol, can be measured spectrophotometrically at 560 nm
by an ELISA plate reader. To visualize DNA condensation
in nuclei, the control and treated cells were incubated in
serum-free DMEM for 3 h and stained with DAPI (0.5 μg/
ml in PBS) according to the manufacturer's instructions
and then examined under fluorescence microscope.
SDS-PAGE and immunoblot analyses
Cell lysates were resolved by 10% SDS-PAGE in Hoefer
vertical gel apparatuses (Amersham Biosciences), fol-
lowed by electrophoretic transfer to polyvinylidene diflu-
oride membranes. The membranes were blocked with 5%
skim milk powder in 5 mM Tris-HCl, pH 7.4, 136 mM
NaCl, 0.1% Tween-20 (TBST buffer) for 1 h and incubated
with primary antibody (5–10 μg/ml) in blocking buffer.
The membranes were washed in TBST, and then incubated
with horseradish peroxidase-conjugated secondary anti-
body. The proteins were detected on a Biomax ML film
using the supersignal west pico chemiluminescent sub-
strate kit (Pierce).
Immunoprecipitation assay
Integrin α5β1 protein was incubated with anti-integrin
α5β1 antibody (200 μg/ml) and protein A/G beads (Santa
Cruz Biotechnology, Santa Cruz, USA) at room tempera-
ture for 2 h. The resulting beads were then incubated with
globular BSA (G-BSA) or fibrillar BSA (F-BSA) overnight at
4°C. The immunocomplexes were collected by centrifuga-
tion and the pellet was washed with PBS. After three
washes, recovered immunocomplexes were solubilized in
sample buffer solution containing 1% SDS and β-mercap-
toethanol, boiled for 10 min, and separated by 10% SDS-
PAGE. The proteins were revealed by immunoblotting
with anti-integrin α5 and anti-BSA antibodies.BMC Biotechnology 2009, 9:2 http://www.biomedcentral.com/1472-6750/9/2
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Caspase-3 activity assay
Caspase-3 activity was determined by the cleavage of the
fluorometric substrate z-DEVD-AMC (Upstate Biotech-
nology, Lake Placid, USA) according to the manufacturer's
instructions. In brief, cells were harvested and washed
twice in PBS, and lysed in a lysis buffer (Pierce) supple-
mented with protease inhibitor mixture (Sigma). The
lysates underwent centrifugation at 12,000 × g for 15 min
at 4°C, and protein concentrations in the supernatants
were determined by use of Bio-Rad Protein Assay. An
amount of 50 μg of the cell lysates were incubated with 72
μM z-DEVD-AMC at room temperature for 15 min in trip-
licate. Cleavage of z-DEVD-AMC was determined by
measurement of emission at 460 nm after excitation at
380 nm with the fluorescence plate reader.
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